Nexo Therapeutics

Nexo Therapeutics is a small-molecule oncology company dedicated to discovering and developing new drugs for cancer patients who currently lack effective treatments. Nexo combines covalent ligand discovery chemical biology with expertise in cancer biology and medicinal chemistry to target the fundamental drivers of cancer through innovative approaches. Nexo has facilities in Golden, Colorado, and Watertown, Massachusetts, and is led by its founder and CEO, Dr. Andrew Phillips.